Genetic predictors of an unfavorable course of severe congenital neutropenia in patients with ELANE gene mutation

Cover Page

Cite item

Full Text

Abstract

Severe congenital neutropenia (SCN) is a rare genetically determined disease with disruption of granulocyte maturation in bone marrow, resulting in a high risk of life-threatening infections. The disease is caused by ELANE gene mutation in the majority (60-80%) of patients. Our study confirms the data of the Severe Congenital Neutropenia International Registry: we have demonstrated an association of ELANE gene mutations (in C151 and G214 positions) with a particularly severe disease course, manifesting by resistance to therapy with granulocyte colony-stimulating factor and the development of myelodysplastic syndrome.

About the authors

Ekaterina A. Deordieva

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Author for correspondence.
Email: deor2005@yandex.ru
Russian Federation

Tatyana V. Varlamova

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: varltatwell@mail.ru
Russian Federation

Elena V. Raikina

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: e_raikina@inbox.ru
Russian Federation

Anna Yu. Shcherbina

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: shcher26@hotmail.com
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Deordieva E.A., Varlamova T.V., Raikina E.V., Shcherbina A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.